Groundbreaking programme will deliver a scalable AI framework, school-based research pilots, teacher playbooks, and ethical governance integrated with EiM’s digital ecosystem to support students in an AI world. Education in Motion (EiM), a global leader in pioneering educational excellence, today announced a new AI in education initiative in partnership with Dr Rose Luckin, Professor Emeritus […]

(Euronext Amsterdam:ASML),(NASDAQ:ASML), ASML reports EUR32.7 billion total net sales and EUR9.6 billion net income in 2025ASML expects 2026 total net sales to be between EUR34 billion and EUR39 billion, with a gross margin between 51% and 53% VELDHOVEN, the Netherlands, January 28, 2026 – Today, ASML Holding NV (ASML) has published its 2025 fourth-quarter and

ASML reports EUR32.7 billion total net sales and EUR9.6 billion net income in 2025 GlobeNewswire January 28, 2026 ASML reports EUR32.7 billion total net sales and EUR9.6 billion net income in 2025ASML expects 2026 total net sales to be between EUR34 billion and EUR39 billion, with a gross margin between 51% and 53% VELDHOVEN, the

HepatoBurn Investigated (SAFETY REPORT) Is This Liver Formula Legit? Side Effects, Risks, and Warnings Explained GlobeNewswire January 28, 2026 Las Vegas, Nevada, Jan. 28, 2026 (GLOBE NEWSWIRE) — If you are researching HepatoBurn reviews in 2026, you are not alone. Interest in this supplement has surged quietly, not because of viral ads or influencer hype,

Not intended for the UK Apecotrep (BI 764198) is a potential first-in-class, oral, selective TRPC6 inhibitor being investigated as a novel, targeted, non-immunosuppressive therapy in people with primary focal segmental glomerulosclerosis (FSGS). Primary FSGS is a rare kidney condition in which injury and loss of podocytes, the cells responsible for the kidney's filtration system, lead

Boehringer Ingelheim's investigational asset apecotrep delivers proteinuria reduction in Phase II kidney trial GlobeNewswire January 28, 2026 Not intended for the UK Apecotrep (BI 764198) is a potential first-in-class, oral, selective TRPC6 inhibitor being investigated as a novel, targeted, non-immunosuppressive therapy in people with primary focal segmental glomerulosclerosis (FSGS). Primary FSGS is a rare kidney

Singapore, Singapore–(Newsfile Corp. – January 28, 2026) – Lithosphere, an AI-powered blockchain ecosystem focused on interoperability and automation, announced enhancements to its developer tooling aimed at supporting the creation and scaling of decentralized applications. The updated tooling framework is designed to simplify development workflows while enabling builders to deploy applications that operate efficiently across multichain

New Analysis of 1 Billion+ Reviews and Contributions Shows Experiences Driving Travel Planning Tripadvisor®, the world’s largest travel guidance platform, today announced the launch of its second annual Trendcast report, exploring the trends defining travel this year. Informed by Tripadvisor’s global insights, the 2026 Trendcast is based on search, booking and behavioral data, along with

“State of Tobacco Control” report urges states to step up and protect residents as federal progress stalls The American Lung Association released its 24th annual “State of Tobacco Control” report today, warning that the largest federal rollback of tobacco prevention efforts in decades is putting hard-won progress at risk. Tobacco use remains the nation’s leading

DDL and MDL dramatically increased as number of filings declined for first time in two years. The number of securities class action filings decreased for the first time in two years in 2025, while the overall size of filings increased substantially, according to a report released today by Cornerstone Research and the?Stanford Law School Securities